Cornerstone Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,773
Closed -$27.2K – 288
2024
Q2
$27.2K Hold
1,773
– – ﹤0.01% 299
2024
Q1
$29.1K Sell
1,773
-581,958
-100% -$9.18M ﹤0.01% 313
2023
Q4
$8.55M Buy
583,731
+17,500
+3% +$244K 0.38% 68
2023
Q3
$8.16M Sell
566,231
-123,259
-18% -$1.92M 0.38% 64
2023
Q2
$11.3M Sell
689,490
-126,592
-16% -$2.06M 0.54% 48
2023
Q1
$13.6M Sell
816,082
-1,367,762
-63% -$22M 0.63% 46
2022
Q4
$33.7M Buy
2,183,844
+308,630
+16% +$4.78M 1.66% 10
2022
Q3
$28M Buy
1,875,214
+632,161
+51% +$10.5M 1.38% 11
2022
Q2
$20.4M Buy
1,243,053
+741,953
+148% +$12.7M 1.07% 20
2022
Q1
$10.1M Buy
+501,100
New +$10.4M 0.59% 45
2021
Q2
– Sell
-459,157
Closed -$12.1M – 203
2021
Q1
$12.1M Buy
+459,157
New +$13M 1.06% 24
2020
Q4
– Sell
-89,000
Closed -$2.12M – 172
2020
Q3
$2.12M Buy
+89,000
New +$2.05M 0.19% 113

Other funds holding BMEZ

Cornerstone Advisors's BMEZ Position: Q3 2024 in Review

Cornerstone Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2024, closing a stake of 1,773 shares — an estimated $27.2K sold.

Cornerstone Advisors first reported a position in BMEZ in Q3 2020 and held it in 12 quarters. The position peaked at $33.7M in Q4 2022. 92 funds tracked by Wall St. Rank hold BMEZ as of Q3 2024.

  • Cornerstone Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q3 2024 after selling out during the quarter.
  • Cornerstone Advisors sold 1,773 BlackRock Health Sciences Trust II shares in Q3 2024, an estimated $27.2K.
  • Cornerstone Advisors first reported a position in BlackRock Health Sciences Trust II in Q3 2020 and held it in 12 quarters.
  • Cornerstone Advisors's BlackRock Health Sciences Trust II position peaked at $33.7M in Q4 2022.
  • 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2024.

Based on Cornerstone Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.